Diagnostic of inflammation in pediatric patients;Entzündungsdiagnostik in der pädiatrie

LaboratoriumsMedizin

Volumn 26, Issue 5-6, 2002, Pages 335-340

  Kunz, Dagmar ^a   Kohse, Klaus P ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b KLINIKUM OLDENBURG   (Germany)

Author keywords

HLA DR of monocytes; IL 6; IL 8; Neonatal sepsis; PCT

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN;

AGE; ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CLINICAL CHEMISTRY; CLINICAL LABORATORY; CYTOKINE PRODUCTION; DECISION MAKING; DIAGNOSTIC ACCURACY; EVALUATION; FINANCE; HUMAN; HUMAN TISSUE; INFLAMMATION; LABORATORY TEST; MONOCYTE; PEDIATRICS; PREDICTION; REFERENCE VALUE; STANDARD; STANDARDIZATION;

EID: 0036301796     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0477.2002.02064.x     Document Type: Article

References (31)

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
2. Definition for Sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
3. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin 8 and C-reactive protein as marker of bacterial infection
4. C-reactive protein and procalcitonin as infection parameters in children with oncologic diseases
5. Procalcitonin in paediatric cancer patients: Its diagnostic relevance is superior to that of C-reactive protein, interleukin-6, interleukin-8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II
6. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants
7. Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates
8. Interleukin 6 as early mediator in neonatal sepsis
9. Interleukin-6: A sensitive parameter for the early diagnosis of neonatal bacterial infection
10. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection
11. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation
12. Interleukin-6 concentrations in neonates evaluated for sepsis
13. Contribution of interleukin-6 in distinguishing between mild respiratory disease and neonatal sepsis in the newborn infant
14. Interleukin-8 in neonatal sepsis
15. Interleukin in hemolysate of neonates' whole blood
16. Determination of total interleukin-8 in whole blood after cell lysis
17. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-a, interleukin (I1-)- 1β, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis
18. Evaluation of interleukin-6, tumour necrosis factor-α and interleukin-1β for early diagnosis of neonatal sepsis
19. Cord blood levels of cytokines as predictors of early neonatal sepsis
20. Neutrophil CD11b expression and circulating Interleukin-8 as diagnostic markers for early-onset neonatal sepsis
21. Early diagnostic markers for neonatal sepsis: Comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules
22. Reactive hyperemia and interleukin 6, interleukin 8 and tumor necrosis factor-α in the diagnosis of early-onset neonatal sepsis
23. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: Reference intervals and analysis if maternal and perinatal con founders
24. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro
25. Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock
26. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children
27. Gibt es eine gesicherte immuntherapie bei der sepsis?
28. Immunological monitoring of the inflammatory process: Which viables? When to assess?
29. Reduced CD4 and HLA-DR expression in neonatal monocytes
30. Flow cytometric measurement of HLA-DR expression on circulating monocytes in healthy and sick neonates using monocyte negative selection
31. Besondere aspekte der entzündungsdiagnostik in der pädiatrischen intensivmedizin nach herzchirurgischen operationen